Using telehealth to improve lung cancer screening decision-making

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pragmatic trial aims to determine if telehealth strategies can enhance shared decision-making (SDM) for lung cancer screening among patients. It employs a Sequential Multiple Assignment Randomized Trial (SMART) design, which includes two stages of interventions: initial patient outreach to schedule telehealth or in-person SDM visits, followed by text message reminders or phone-based digital care coordination for non-responders. The study also evaluates the effectiveness of these strategies across different races and sexes to ensure equitable access to lung cancer screening.

Why it matters

Who can join: the full rules

Inclusion criteria:

Participants will be eligible if:

1. are aged 50 to 80
2. have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey
3. currently smoke or formerly smoked cigarettes
4. have no documented history of lung cancer
5. have no documented history of lung cancer screening in the 24 months prior to study enrollment
6. have completed at least one primary care visit at Penn Medicine in the 3 years prior to study enrollment.

Exclusion criteria:

Participants who do not meet inclusion criteria will not be eligible.

Where it's running

• University of Pennsylvania
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Katharine Rendle, PhD — Abramson Cancer Center
• Study coordinator: Katharine Rendle, PhD
• Email: katharine.rendle@pennmedicine.upenn.edu
• Phone: 215-349-5442

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease

  This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.

  Recruiting Lithuanian University of Health Sciences · Kulautuva · NCT07927829

• Methylation markers in self-samples to help detect gynecological cancers

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902375

• How vaccine-related inflammation may affect how doctors make treatment decisions

  This study tests whether a mild inflammatory state from a flu shot changes decision-making in emergency and internal medicine clinicians.

  Recruiting at 3 sites Phase 2 University of Arkansas, Fayetteville · Fayetteville, Arkansas and 2 other locations · NCT07842367

• Tele-diabetes remote monitoring for kids with type 1 diabetes

  This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.

  Recruiting Sheba Medical Center · Ramat Gan · NCT07828106

• Testing Alcohol Health Warning Labels for US Adults

  A randomized online study will test different warning statements about alcohol and breast cancer risk among adult US women who drink or are young non-drinkers to see which warnings are most convincing.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07812545

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.